| Literature DB >> 31690303 |
Wu Sun1, Jing-Hua Gao1, Li-Guo Zhu2, Wei Xiao3, Zhen-Zhong Wang3, Ke-Xin Yang1, Qing Zhang1, Bao-Jian Wang1.
Abstract
BACKGROUND: Wound-related complications are an inevitable issue faced by spinal surgeons. Negative pressure drainage remains the most commonly used method to prevent postoperative hematoma and related complications. This prospective, randomized, controlled study was conducted to evaluate the efficacy of compression therapy following posterior lumbar interbody fusion, with emphasis on pain, anemia, and inflammation.Entities:
Keywords: Anemia; Compression therapy; Lumbar spine surgery; Pain
Mesh:
Year: 2019 PMID: 31690303 PMCID: PMC6833233 DOI: 10.1186/s12893-019-0612-7
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.102
Inclusion and exclusion criteria
| Inclusion criteria | Exclusion criteria |
|---|---|
| Age > 40 years [ | ≤40 years of age |
| Low back pain/intermittent claudication | Decompression without internal fixation [ |
| CT/MRI confirmed lumbar spinal stenosis | Back or leg pain of unknown etiology |
| Failed conservative treatment for 2 weeks | Systemic or local infections |
| Posterior lumbar decompression, internal fixation, and interbody fusion | Chronic steroid use, diabetes, hemato-oncological disease, renal disease, autoimmune disease [ |
| Blood Transfusion in perioperative period |
Fig. 1Dressing was folded into a shuttle shape to counteract the lumbar lordosis
Fig. 2Cuff sphygmomanometer used for marking lines at 20 and 40 mmHg
Fig. 3Cuff sphygmomanometer used for marking lines at 20 and 40 mmHg
Fig. 4Elastic waist band worn between the two marked lines
Fig. 5CONSORT flowchart exhibiting the recruitment process of participants into the trial
Comparison of general data and laboratory indices between the treatment and control groups before the intervention
| Treatment group ( | Control group ( | |||||||
|---|---|---|---|---|---|---|---|---|
| n | Mean (SD) | n | Mean (SD) | χ2-value | z-value | t-value | ||
| Age | 57.77 (9.02) | 60.43 (9.06) | – | – | −1.14 | 0.26 | ||
| Gender | 0.07 | – | – | 0.79 | ||||
| Male | 12 | 11 | ||||||
| Female | 18 | 19 | ||||||
| BMI | 26.11 (3.61) | 26.51 (3.06) | – | – | −0.46 | 0.64 | ||
| Surgical segment (number) | 2.40 (0.56) | 3.00 (0.52) | – | −3.89 | – | 0.09 | ||
| Surgery duration (min) | 175.67 (42.48) | 180.67 (30.05) | – | – | −0.53 | 0.60 | ||
| Blood loss (mL) | 282.33 (92.87) | 337.33 (131.20) | – | −1.58 | – | 0.11 | ||
| Laboratory indexes | ||||||||
| WBC (10^9/L) | 5.97 (1.55) | 5.91 (1.42) | – | – | 0.16 | 0.87 | ||
| RBC (10^9/L) | 4.63 (0.46) | 4.54 (0.49) | – | – | 0.73 | 0.47 | ||
| Hb (g/L) | 140.33 (15.40) | 140.30 (14.42) | – | – | 0.01 | 0.99 | ||
Comparison of general data and laboratory indices between the treatment and control groups after the intervention
| Treatment group ( | Control group ( | ||||
|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | z-value | t-value | ||
| Drainage volume (mL) | 332.33 (131.98) | 447.00 (178.46) | – | −2.83 | 0.006* |
| Maximum VAS (cm) | 3.07 (1.20) | 4.00 (1.13) | −3.26 | – | 0.001* |
| WBC1 (10^9/L) | 12.78 (3.21) | 12.60 (2.99) | – | 0.223 | 0.825 |
| RBC1 (10^9/L) | 4.02 (0.70) | 3.76 (0.49) | – | 1.656 | 0.103 |
| Hb1 (g/L) | 119.10 (15.17) | 116.1 (14.38) | – | 0.786 | 0.435 |
| ESR1 (mm/h) | 13.97 (8.59) | 12.80 (10.67) | – | 0.466 | 0.643 |
| CRP1 (mg/L) | 24.20 (16.81) | 32.35 (18.77) | – | −1.771 | 0.082 |
| WBC3 (10^9/L) | 10.83 (2.76) | 10.20 (2.27) | – | 0.964 | 0.339 |
| RBC3 (10^9/L) | 3.84 (0.50) | 3.46 (0.53) | – | 2.896 | 0.005* |
| Hb3 (g/L) | 116.77 (13.54) | 107.1 (15.99) | – | 2.527 | 0.014* |
| ESR3 (mm/h) | 32.30 (22.65) | 34.73 (26.96) | – | −0.378 | 0.706 |
| CRP3 (mg/L) | 44.06 (48.64) | 60.23 (51.43) | – | −1.251 | 0.216 |
| WBC10 (10^9/L) | 8.48 (1.77) | 7.57 (2.38) | – | 1.676 | 0.099 |
| RBC10 (10^9/L) | 5.68 (2.27) | 4.66 (1.54) | – | 2.040 | 0.047* |
| Hb10 (g/L) | 120.37 (14.77) | 109.53 (22.26) | – | 2.221 | 0.030* |
| ESR10 (mm/h) | 34.90 (20.01) | 34.59 (22.31) | – | 0.056 | 0.955 |
| CRP10 (10^9/L) | 13.87 (11.24) | 23.14 (19.30) | – | −2.273 | 0.028* |
*Statistical difference (p < 0.05)
1First day after the operation; 33rd day after the operation; 1010th day after the operation
Fig. 6Comparative graphical representation of changes in the RBC count (10^9/L) in the treatment and control groups
Fig. 7Comparative graphical representation of changes in Hb levels (g/L) in the treatment and control groups
Fig. 8Comparative plots of changes in CRP levels (mg/L) in the treatment and control groups